Cinqair

CINQAIR (Reslizumab)

 

  • Cinqair is also a medication for patients with eosinophilic asthma. It is also works by reducing the number of eosinophils in your blood.
  • Cinqair is administered as an intravenous infusion (through the vein). It takes about 20 to 50 minutes to receive the infusion. It is given once every four weeks.
  • After you receive a dose of Cinqair, most infusion centers will monitor you for a period of time to make sure you do not have any reactions to the medication. 
  • The most common side effects with Cinqair are: 
  • Sore throat
  • Muscle aches
  • Severe allergic reaction (Rare)